Protection from obesity-induced insulin resistance in mice lacking TNF-α function
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-alpha is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans and it blocks the action of insulin in cultured cells and whole animals. To investigate the role of TNF-alpha in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-alpha and those encoding the two receptors for TNF-alpha. The absence of TNF-alpha resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFalpha-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-alpha is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of animal studies where inflammatory pathways are genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [159]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“gif" NDATA ITEM> ]> Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitu”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932 · cited 1×
“To test the importance of the TNFα-activated pathway of insulin resistance in the most severe, genetic model of obesity, we generated genetically obese ( ob/ob ) mice with targeted mutations in both p55 and p75 TNF receptors, effectively abolishing the signalling and function of TNF-α in these animal”
BackgroundHotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cited by
Items 301–400 of 1,010
Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
Wieser, V., Moschen, A. R., & Tilg, H. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0210-1 · Cited by 241
“Further evidence supporting a key role for TNF-a in insulin resistance came from studies where they observed that mice lacking TNF-a or TNF receptors had improved insulin sensitivity in both dietary and genetic (ob/ob) models of obesity (Uysal et al. 1997).”
BackgroundSpecific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis
Caballero, F., Fernández, A., Matías, N., Martínez, L., Fucho, R., Elena, M., Caballeria, J., Morales, A., Fernández-Checa, J. C., & García-Ruiz, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099333 · Cited by 238
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review
Wali, J. A., Jarzebska, N., Raubenheimer, D., Simpson, S. J., Rodionov, R. N., & O’Sullivan, J. F. (2020) · Nutrients · doi:10.3390/nu12051505 · Cited by 235
Katagiri, H., Yamada, T., & Oka, Y. (2007) · Circulation Research · doi:10.1161/circresaha.107.151621 · Cited by 235
WANG, X., BI, Y., ZHANG, Q., & PAN, F. (2013) · Respirology · doi:10.1111/j.1440-1843.2012.02267.x · Cited by 234
Franckhauser, S., Muñoz, S., Pujol, A., Casellas, A., Riu, E., Otaegui, P., Su, B., & Bosch, F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.624 · Cited by 233
Angiogenesis and development of adipose tissue
Christiaens, V., & Lijnen, H. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.006 · Cited by 231
“A functional role of TNF- in adipogenesis and insulin resistance has been studied in the genetically obese and diabetic ob/ob mice (Uysal et al., 1997).”
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Fon Tacer, K., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 231
“Inflammatory cytokine TNF-α is overexpressed in the liver of obesemice andmediates insulin resistance [125, 126].”
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
Giorgino, F., Laviola, L., & Eriksson, J. W. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01385.x · Cited by 230
Diabetes, Hyperglycemia, and Inflammation in Older Individuals
de Rekeneire, N., Peila, R., Ding, J., Colbert, L. H., Visser, M., Shorr, R. I., Kritchevsky, S. B., Kuller, L. H., Strotmeyer, E. S., Schwartz, A. V., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2327 · Cited by 230
“Obesity appears to be a state of chronic inflammation with increased production of cytokines and other acutephase reactants that play a crucial role in regulation of systemic insulin action; it has been shown that TNF- – deficient mice show increased insulin action (30).”
Backgroundvan Dielen, F., van't Veer, C., Schols, A., Soeters, P., Buurman, W., & Greve, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801825 · Cited by 230
Teruel, T., Hernandez, R., & Lorenzo, M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2563 · Cited by 230
Insulin Resistance and Substrate Utilization in Human Endotoxemia
Agwunobi, A. O., Reid, C. L., Maycock, P. F., Little, R. A., & Carlson, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3770 · Cited by 230
“TNF infusion induces insulin resistance in rodents by impairing insulin-mediated glucose disposal (24), and there has been recent evidence to suggest a role for TNF as a mediator of insulin resistance in obesity and diabetes (33).”
BackgroundApproach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
Medina, J., Fernández-Salazar, L. I., García-Buey, L., & Moreno-Otero, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2057 · Cited by 229
Saito, T., Shimazaki, Y., Kiyohara, Y., Kato, I., Kubo, M., Iida, M., & Koga, T. (2004) · Journal of Dental Research · doi:10.1177/154405910408300610 · Cited by 229
“Tumor necrosis factor alpha (TNF- ), which is produced from the increased amounts of adipose tissue in obese subjects, plays a predominant role in insulin resistance (Uysal et al., 1997; Zinman et al., 1999).”
BackgroundHigh Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions
Zhang, D.-M., Jiao, R.-Q., & Kong, L.-D. (2017) · Nutrients · doi:10.3390/nu9040335 · Cited by 228
Zhao, Y., Banerjee, S., Dey, N., LeJeune, W. S., Sarkar, P. S., Brobey, R., Rosenblatt, K. P., Tilton, R. G., & Choudhary, S. (2011) · Diabetes · doi:10.2337/db10-1262 · Cited by 228
Insulin Resistance in Alzheimer's Disease
Ferreira, L. S. S., Fernandes, C. S., Vieira, M. N. N., & De Felice, F. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 228
“Conversely, TNF-α depletion protects mice from obesity-induced insulin resistance (Uysal et al., 1997).”
BackgroundMetabolic Syndrome: Focus on Dyslipidemia
Ginsberg, H. N., Zhang, Y., & Hernandez‐Ono, A. (2006) · Obesity · doi:10.1038/oby.2006.281 · Cited by 228
Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors
Missiha, S. B., Ostrowski, M., & Heathcote, E. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.069 · Cited by 228
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Tilg, H. (2010) · Digestive Diseases · doi:10.1159/000282083 · Cited by 227
“more than a decade ago. These authors presented the concept of inflammation in obesity and provided evidence that adipocytes express TNF-α and that expression of this cytokine in obese animals ( fa/fa rat and ob/ob mouse) is increased. IR could be improved by antibody neutralization of TNF-α. These observations were l…”
ResultSamad, F., Uysal, K. T., Wiesbrock, S. M., Pandey, M., Hotamisligil, G. S., & Loskutoff, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6902 · Cited by 226
Self-citationPerivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
Qi, X.-Y., Qu, S.-L., Xiong, W.-H., Rom, O., Chang, L., & Jiang, Z.-S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0777-x · Cited by 226
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A. C., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 225
Chapter 21 Interleukin‐6 and Insulin Resistance
Kim, J., Bachmann, R. A., & Chen, J. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00621-3 · Cited by 224
“TNF-a-deficient obese mice are protected from obesity-related insulin resistance in muscle and fat tissues (Uysal et al., 1997).”
TNF in the liver: targeting a central player in inflammation
Tiegs, G., & Horst, A. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00910-2 · Cited by 224
Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance
Maeda, K., Uysal, K. T., Makowski, L., Görgün, C. Z., Atsumi, G., Parker, R. A., Brüning, J., Hertzel, A. V., Bernlohr, D. A., & Hotamisligil, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.300 · Cited by 224
Self-citationDiabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells
D'Souza, D. M., Al-Sajee, D., & Hawke, T. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00379 · Cited by 223
“…Swaroop et al., 2012), it has also been found to alter insulin-mediated glucose uptake in muscle cells in vitro (Yoon et al., 2011), and has been implicated in the development of insulin resistance through studies knocking out its respective receptors (Uysal et al., 1997; Romanatto et al., 2009).”
BackgroundMalaguarnera, M., Gargante, M. P., Russo, C., Antic, T., Vacante, M., Malaguarnera, M., Avitabile, T., Li Volti, G., & Galvano, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.719 · Cited by 223
Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real, J. M., Broch, M., Ricart, W., Casamitjana, R., Gutierrez, C., Vendrell, J., & Richart, C. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1757 · Cited by 223
Wellen, K. E., Fucho, R., Gregor, M. F., Furuhashi, M., Morgan, C., Lindstad, T., Vaillancourt, E., Gorgun, C. Z., Saatcioglu, F., & Hotamisligil, G. S. (2007) · Cell · doi:10.1016/j.cell.2007.02.049 · Cited by 222
“Experiments with loss-of-function mouse models have demonstrated the central role of these inflammatory pathways in metabolic diseases (Uysal et al., 1997; Yuan et al., 2001; Hirosumi et al., 2002; Howard et al., 2004; Arkan et al., 2005; Cai et al., 2005).”
BackgroundYan, F., Li, N., Shi, J., Li, H., Yue, Y., Jiao, W., Wang, N., Song, Y., Huo, G., & Li, B. (2019) · Food & Function · doi:10.1039/c9fo01062a · Cited by 222
A decade of progress in adipose tissue macrophage biology
Hill, A. A., Reid Bolus, W., & Hasty, A. H. (2014) · Immunological Reviews · doi:10.1111/imr.12216 · Cited by 222
Cytokines and β-Cell Biology: from Concept to Clinical Translation
Donath, M. Y., Størling, J., Berchtold, L. A., Billestrup, N., & Mandrup-Poulsen, T. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0033 · Cited by 222
Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling
Shi, H., Tzameli, I., Bjørbæk, C., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403886200 · Cited by 222
p53 Activation in Adipocytes of Obese Mice
Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220
Patel, V. B., Shah, S., Verma, S., & Oudit, G. Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9644-1 · Cited by 218
Adipose Inflammation, Insulin Resistance, and Cardiovascular Disease
Shah, A., Mehta, N., & Reilly, M. P. (2008) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108325251 · Cited by 217
Gottlieb, A. B., Chao, C., & Dann, F. (2008) · Journal of Dermatological Treatment · doi:10.1080/09546630701364768 · Cited by 216
Kelley, G. L., Allan, G., & Azhar, S. (2004) · Endocrinology · doi:10.1210/en.2003-1167 · Cited by 216
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 215
Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., Andoh, Y., Fujii, S., Iwabuchi, K., Onoé, K., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.198614 · Cited by 215
Steatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215
Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging
Sztretye, M., Dienes, B., Gönczi, M., Czirják, T., Csernoch, L., Dux, L., Szentesi, P., & Keller-Pintér, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3849692 · Cited by 214
“Palmitate generate ceramide which triggers mitochondrial oxidative stress and insulin resistance [87], and the role of TNFα in the generation of insulin resistance was also shown [86].”
BackgroundStewart, L. K., Flynn, M. G., Campbell, W. W., Craig, B. A., Robinson, J. P., McFarlin, B. K., Timmerman, K. L., Coen, P. M., Felker, J., & Talbert, E. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.04.003 · Cited by 213
“critical role in the regulation of insulin resistance in obesity (Lang et al., 1992; Lechleitner et al., 2002; Uysal et al., 1997; Van der Poll et al., 1991).”
BackgroundGao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L., & Bing, C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2013 · Cited by 213
Macrophage function in obesity-induced inflammation and insulin resistance
Lauterbach, M. A. R., & Wunderlich, F. T. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1955-5 · Cited by 212
Paquot, N. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1316 · Cited by 212
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210
“TNFα depletion in ob/ob genetic or diet-induced obese mice reduces insulin resistance and improves insulin signaling in adipose tissue and muscle [221].”
BackgroundTorpor in mice is induced by both leptin-dependent and -independent mechanisms
Gavrilova, O., Leon, L. R., Marcus-Samuels, B., Mason, M. M., Castle, A. L., Refetoff, S., Vinson, C., & Reitman, M. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14623 · Cited by 210
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells
Cramer, C., Freisinger, E., Jones, R. K., Slakey, D. P., Dupin, C. L., Newsome, E. R., Alt, E. U., & Izadpanah, R. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0009 · Cited by 209
“TNF-a is often elevated in obese and diabetic patients, and plays an important role in insulin resistance and cell survival [23,24].”
White adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
“The secretion of tumour necrosis factor (TNF) has, for example, in rodents been shown to directly reduce adipocyte insulin sensitivity 78,79 .”
Gehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 209
Guerre-Millo, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344048 · Cited by 209
Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity
De Taeye, B. M., Novitskaya, T., McGuinness, O. P., Gleaves, L., Medda, M., Covington, J. W., & Vaughan, D. E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00194.2007 · Cited by 208
Adipose tissue: an endocrine organ playing a role in metabolic regulation
Booth, A., Magnuson, A., Fouts, J., & Foster, M. T. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0073 · Cited by 208
Ziolkowska, S., Binienda, A., Jabłkowski, M., Szemraj, J., & Czarny, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011128 · Cited by 207
The interplay between inflammation and metabolism in rheumatoid arthritis
Chimenti, M. S., Triggianese, P., Conigliaro, P., Candi, E., Melino, G., & Perricone, R. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.246 · Cited by 207
Newman, J. C., He, W., & Verdin, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.404863 · Cited by 207
Agrawal, N., Delanoue, R., Mauri, A., Basco, D., Pasco, M., Thorens, B., & Léopold, P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.003 · Cited by 206
“TNF-a is expressed at high levels in muscles and white adipose tissue of obese human and mice (Hotamisligil et al., 1993; Hotamisligil et al., 1995), and its removal ameliorates insulin sensitivity (Hotamisligil et al., 1994; Uysal et al., 1997).”
BackgroundGrace, M. S., Formosa, M. F., Bozaoglu, K., Bergouignan, A., Brozynska, M., Carey, A. L., Veiga, C. B., Sethi, P., Dillon, F., Bertovic, D. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40490-0 · Cited by 205
The Role of Inflammation in β-cell Dedifferentiation
Nordmann, T. M., Dror, E., Schulze, F., Traub, S., Berishvili, E., Barbieux, C., Böni-Schnetzler, M., & Donath, M. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-06731-w · Cited by 204
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
“genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
BackgroundAdipose tissue inflammation and ectopic lipid accumulation [Review]
Suganami, T., Tanaka, M., & Ogawa, Y. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0271 · Cited by 203
Carter-Kent, C., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01709.x · Cited by 203
Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
Grant, R. W., & Dixit, V. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00050 · Cited by 203
“Consistent with these clinical findings, mechanistic studies using Tnf α gene knockout mice or neutralization of TNF with antibodies improved glycemia in obese mice and rats, respectively, making it a potential therapeutic target for T2D (Hotamisligil et al., 1994a; Uysal et al., 1997).”
BackgroundResultHypothalamic Inflammation in the Control of Metabolic Function
Valdearcos, M., Xu, A. W., & Koliwad, S. K. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071656 · Cited by 201
Angiopoietin-related growth factor antagonizes obesity and insulin resistance
Oike, Y., Akao, M., Yasunaga, K., Yamauchi, T., Morisada, T., Ito, Y., Urano, T., Kimura, Y., Kubota, Y., Maekawa, H., et al. (2005) · Nature Medicine · doi:10.1038/nm1214 · Cited by 200
McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., & Roche, H. M. (2011) · Diabetes · doi:10.2337/db10-1278 · Cited by 199
Altintas, M. M., Azad, A., Nayer, B., Contreras, G., Zaias, J., Faul, C., Reiser, J., & Nayer, A. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011338 · Cited by 198
Satapathy, S. K., Garg, S., Chauhan, R., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40220.x · Cited by 198
Liu, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1676 · Cited by 198
“Inhibition of insulin receptor signaling is a central mechanism through which obesity-related metabolic and inflammatory stresses induce insulin resistance.(4,5) Alternatively, reverse causation may also be possible.”
BackgroundSelf-citationResponses to ozone are increased in obese mice
Shore, S. A., Rivera-Sanchez, Y. M., Schwartzman, I. N., & Johnston, R. A. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00336.2003 · Cited by 197
Green, E. A., Eynon, E. E., & Flavell, R. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80670-6 · Cited by 197
Local estrogen biosynthesis in males and females.
Simpson, E., Rubin, G., Clyne, C., Robertson, K., O'Donnell, L., Davis, S., & Jones, M. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060131 · Cited by 196
“Significantly in his context, mice lacking TNF α function are protected from obesity-induced insulin-resistance (Uysal et al. 1997).”
BackgroundImpact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia
Gutierrez, D. A., Puglisi, M. J., & Hasty, A. H. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0006-9 · Cited by 194
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
Lafontan, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095843 · Cited by 194
Inflammation links excess fat to insulin resistance: the role of the interleukin‐1 family
Tack, C. J., Stienstra, R., Joosten, L. A. B., & Netea, M. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01145.x · Cited by 193
“Additionally, mice deficient in TNF-a showed improved insulin sensitivity in dietinduced obesity (103).”
BackgroundAdipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
Exercise Induced Adipokine Changes and the Metabolic Syndrome
Golbidi, S., & Laher, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/726861 · Cited by 192
“Even though acute episodes of exercise might be associated with increased levels of inflammatory cytokines, exercise training reduces circulating levels of inflammatory markers, even in lean individuals [113].”
BackgroundMetabolic inflammation: Connecting obesity and insulin resistance
Dali-Youcef, N., Mecili, M., Ricci, R., & Andrès, E. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.705015 · Cited by 190
Parnell, J. A., Raman, M., Rioux, K. P., & Reimer, R. A. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02730.x · Cited by 189
Inflammatory cause of metabolic syndrome via brain stress and NF-κB
Cai, D., & Liu, T. (2012) · Aging · doi:10.18632/aging.100431 · Cited by 189
Xu, H., Uysal, K. T., Becherer, J. D., Arner, P., & Hotamisligil, G. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1876 · Cited by 189
Self-citationThe complex immunological and inflammatory network of adipose tissue in obesity
Apostolopoulos, V., de Courten, M. P. J., Stojanovska, L., Blatch, G. L., Tangalakis, K., & de Courten, B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500272 · Cited by 187
Sleep and the metabolic syndrome
Wolk, R., & Somers, V. K. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2006.033787 · Cited by 187
“2004), which may lead to insulin resistance (Hotamisligil et al. 1993; Uysal et al. 1997).”
BackgroundSummers, S. A., & Nelson, D. H. (2005) · Diabetes · doi:10.2337/diabetes.54.3.591 · Cited by 185
Bioactive lipids in metabolic syndrome
Nagao, K., & Yanagita, T. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.002 · Cited by 185
Souza, S. C., Palmer, H. J., Kang, Y., Yamamoto, M. T., Muliro, K. V., Eric Paulson, K., & Greenberg, A. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10565 · Cited by 185
“TNF-a stimulates adipocyte lipolysis, and has been hypothesized to contribute to obesity-linked insulin resistance and diabetes [Hotamisligil and Spiegelman, 1994; Hotamisligil et al., 1995; Uysal et al., 1997; Souza et al., 1998].”
BackgroundFujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Abe, M., Shojima, N., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0131 · Cited by 184
Li, J., Diao, B., Guo, S., Huang, X., Yang, C., Feng, Z., Yan, W., Ning, Q., Zheng, L., Chen, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01327-4 · Cited by 183
“Compared to WT littermates, flow cytometric assay showed that the ATMs from Vsig4 −/− obese mice expressed higher amounts of proinflammatory factors (like pro-IL-1β, IFNγ, and TNF), which have been described to actively participate into the pathogenesis of HFD-caused obesity and insulin resistance 26, 27 (Fig.”
Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
Spielman, L. J., Little, J. P., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.004 · Cited by 182
“3–5), since evidence implicating brain inflammation as the potential initiator or aggravator in these diseases is most compelling (Uysal et al., 1997; Sathe et al., 2012; Hsiao et al., 2013).”
Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion
Khasawneh, J., Schulz, M. D., Walch, A., Rozman, J., de Angelis, M. H., Klingenspor, M., Buck, A., Schwaiger, M., Saur, D., Schmid, R. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802864106 · Cited by 182
Inflammation in the pathogenesis of microvascular complications in diabetes
Nguyen, D. V., Shaw, L. C., & Grant, M. B. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00170 · Cited by 181
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180
“In addition to candidate genes, multiple metabolic pathways are also implicated, including aberrant lipogenesis (Roden et al. 1996; Samuel et al. 2004), increased inflammation (Hotamisligil et al. 1993; Uysal et al. 1997), and reduced fatty-acid oxidation (Ji and Friedman 2007, 2008).”
BackgroundVaspin: a novel serpin with insulin-sensitizing effects
Wada, J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.327 · Cited by 180
Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice
Lee, Y.-S., Cha, B.-Y., Choi, S.-S., Choi, B.-K., Yonezawa, T., Teruya, T., Nagai, K., & Woo, J.-T. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.03.014 · Cited by 179
Brachmann, S. M., Ueki, K., Engelman, J. A., Kahn, R. C., & Cantley, L. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1596-1607.2005 · Cited by 179
Metadata
- Authors
- Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Hotamisligil, Gkhan S.
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 610-614
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1764140709
- Cited by
- 2,234
- References
- 26
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 40 · 2023: 48 · 2022: 50 · 2021: 77 · 2020: 79 · 2019: 79 · 2018: 80 · 2017: 96 · 2016: 71 · 2015: 111 · 2014: 106 · 2013: 141 · 2012: 122
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- TNF-α, insulin resistance, obesity, diet-induced obesity, ob/ob mice, free fatty acids, insulin receptor signaling, type 2 diabetes, adipose tissue, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Fatty Acids, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Monosaccharide Transport Proteins, Muscle Proteins, Mutation, Obesity, Phosphorylation, Receptor, Insulin, Triglycerides, Tumor Necrosis Factor-alpha, Signal Transduction, Receptors, Tumor Necrosis Factor, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.